The Prevalence and Determinants of Return to Work in Head and Neck Cancer Survivors: A Scoping Review
- PMID: 36689058
- DOI: 10.1007/s10926-022-10090-3
The Prevalence and Determinants of Return to Work in Head and Neck Cancer Survivors: A Scoping Review
Similar articles
-
The prevalence and determinants of return to work in head and neck cancer survivors.Support Care Cancer. 2019 Feb;27(2):539-546. doi: 10.1007/s00520-018-4343-6. Epub 2018 Jul 16. Support Care Cancer. 2019. PMID: 30014191
-
Returning to work: a qualitative study of the experiences of head and neck cancer survivors.J Laryngol Otol. 2023 Jun;137(6):691-696. doi: 10.1017/S0022215122002201. Epub 2023 Jan 11. J Laryngol Otol. 2023. PMID: 36999532
-
Survey of return to work of head and neck cancer survivors: A report from a tertiary cancer center in India.Head Neck. 2017 May;39(5):893-899. doi: 10.1002/hed.24703. Epub 2017 Feb 7. Head Neck. 2017. PMID: 28170129
-
Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation.Curr Hematol Malig Rep. 2022 Dec;17(6):228-242. doi: 10.1007/s11899-022-00678-0. Epub 2022 Oct 4. Curr Hematol Malig Rep. 2022. PMID: 36194316 Review.
-
Data analytics for predicting quality of life changes in head and neck cancer survivors: a scoping review.Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:2262-2265. doi: 10.1109/EMBC46164.2021.9629619. Annu Int Conf IEEE Eng Med Biol Soc. 2021. PMID: 34891737
Cited by
-
"Women's experiences of head and neck cancer: an interpretative phenomenological analysis".BMC Womens Health. 2025 Mar 28;25(1):145. doi: 10.1186/s12905-025-03671-w. BMC Womens Health. 2025. PMID: 40155998 Free PMC article.
-
Multidimensional fatigue and its impact on work productivity, mood and quality of life in long-term survivors following definitive intensity-modulated radiotherapy for oropharyngeal cancer: A cross-sectional study.J Cancer Surviv. 2025 Jan 18. doi: 10.1007/s11764-024-01735-8. Online ahead of print. J Cancer Surviv. 2025. PMID: 39825989
-
Return to Work Up to 5 Years After the End of Treatment Among Patients With Head and Neck Cancer.JAMA Otolaryngol Head Neck Surg. 2025 Apr 1;151(4):297-310. doi: 10.1001/jamaoto.2024.4991. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 39913126
References
-
- Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60–72. https://doi.org/10.1056/NEJMra1715715 . - DOI - PubMed
-
- Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660 . - DOI - PubMed
-
- Ren Z, Hu C, He H, Li Y, Lyu J. Global and regional burdens of oral cancer from 1990 to 2017: results from the global burden of disease study. Cancer Commun. 2020;40(2–3):81–92. https://doi.org/10.1002/cac2.12009 . - DOI
-
- Miranda-Filho A. Bray F. Global patterns and trends in cancers of the lip, tongue and mouth. Oral Oncol. 2020;102:104551. https://doi.org/10.1016/j.oraloncology.2019.104551 . - DOI - PubMed
-
- Miller A. Returning to work after head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2020;28(3):155–60. https://doi.org/10.1097/MOO.0000000000000628 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical